EP3720879

COMBINATION THERAPY BETWEEN ANTI-PROGASTRIN ANTIBODY AND IMMUNOTHERAPY TO TREAT CANCER

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    5.12.2018
  • EP published:
    11.5.2022
  • EP application number:
    18829742.8
  • Max expiry date:
    4.12.2038
  • Title in English:
    COMBINATION THERAPY BETWEEN ANTI-PROGASTRIN ANTIBODY AND IMMUNOTHERAPY TO TREAT CANCER
  • Language of the patent:
    English

Timeline

Today
5.12.2018EP application
11.5.2022EP Publication

Owner

  • Name:
    Progastrine et Cancers S.à r.l.
  • Address:
    11, Côte d'Eich, 1450 Luxembourg, LU

Inventor

  • Name:
    PRIEUR, Alexandre
  • Address:
    34000 Montpellier, FR

Priority

  • Number:
    201762594755 P
  • Date:
    5.12.2017
  • Country:
    US

Classification

  • Categories:
    C07K 16/26, C07K 16/28, A61K 39/395

Upload documents